Newsletter
Every new paper in this field, in your inbox.
In a game-changing move, researchers explored the "1+2" technique for pancreaticojejunostomy in laparoscopic pancreaticoduodenectomy. Among 184 cases, this approach exhibited success in all 95 "1+2" cases, showcasing advantages over the traditional method. The new technique boasted shorter operation and pancreaticojejunostomy times, reduced complications, lower infection…
Exploring laparoscopic liver surgeries, researchers scrutinized 112 patients undergoing laparoscopically limited anatomic resections (LARs) for hepatocellular carcinoma (HCC) and colorectal liver metastasis (CRLM). Impressively, lap-LAR demonstrated precise technique, yielding promising oncologic outcomes with low complications. Five-year recurrence-free survival rates for HCC and CRLM stood at…
Surviving biliary sepsis: A retrospective study in a cancer center unveils a 30.3% 90-day mortality rate, with factors like metastatic stage, biliary tract tumor compression, and multi-drug resistant bacteria influencing outcomes. Antibiotic de-escalation emerges as a safe strategy, linked with better survival. Beyond organ dysfunctions,…
Hepatitis D Virus (HDV) hitchhikes on Hepatitis B Virus (HBV), impacting 12 to 72 million globally with accelerated liver disease progression. Chronic HDV-HBV infection, deadlier than HBV alone, leads to cirrhosis and hepatocellular carcinoma. Limited awareness hampers diagnosis, but the HBV vaccine offers prevention. Interferon…
In the quest for effective gastroenteropancreatic neuroendocrine carcinoma treatments, researchers unleashed patient-derived tumor spheroids. A dazzling 16 compounds, notably tyrosyl-DNA phosphodiesterase 1 inhibitors, emerged as fierce warriors against over 75% of these rare tumors. Cytarabine, a standout from the bunch, synergized with standard drugs, intensifying…
For severe infected necrotizing pancreatitis, researchers compared endoscopic and minimally invasive surgical (MIS) treatments in a meta-analysis. Analyzing five randomized controlled trials with 284 patients, endoscopic procedures (145 patients) outperformed MIS (139 patients), demonstrating significantly lower complication rates and better patient quality of life.
In the U.S., racial disparities exist in the choice of high- or low-volume hospitals for pancreaticoduodenectomy (PD) surgeries, impacting outcomes. A review of 30 studies reveals that more racial minorities undergo PD in low-volume hospitals. Additionally, disparities in travel distance, education levels, and median income…
In the quest for curative pancreatectomy for pancreatic cancer, researchers delve into arterial resection's (AR) feasibility and outcomes. Analyzing 259 patients, they find AR, despite longer operation times, rivals venous resection in morbidity. Surprisingly, arterial infiltration's likelihood is questioned, suggesting AR might be replaceable by…
A cohort of 761 patients revealed that the acinar score, based on pancreatic acinar content and fibrosis, effectively dichotomized the risk spectrum into high and low risk. This new stratification tool improved predictions compared to the conventional isgps classification, leading to better-targeted mitigation strategies for…
Examining 2534 cases across 58 global centers, this study dissected the impact of cirrhosis on minimally invasive major hepatectomies (MIMH) for liver malignancies. Child-Pugh A cirrhosis correlated with increased morbidity and extended hospital stays. Child-Pugh B cirrhotics faced higher transfusion rates and prolonged hospitalization. However,…
